Year archive

ALTERITY THERAPEUTICS LIMITED — 2026 filings

All 84 regulatory filings released by ALTERITY THERAPEUTICS LIMITED (ATH) in 2026, sourced directly from the official regulator.

84 Filings

2026 Period

2026 filings (84)

Filing	Released	Lang
FORM 6-K Regulatory Filings	2026-07-09	English
FORM 6-K Regulatory Filings	2026-07-09	English
ATH Receives A$3.98m R&D Tax Incentive 3 pages 713.6KB Regulatory Filings	2026-07-09	English
Application for quotation of securities - ATH 8 pages 20.7KB Share Issue/Capital Change	2026-07-09	English
FORM 6-K Regulatory Filings	2026-07-07	English
FDA Meeting Minutes Confirm Registrational Path for ATH434 4 pages 722.8KB Regulatory Filings	2026-07-07	English
Application for quotation of securities - ATH 8 pages 20.7KB Share Issue/Capital Change	2026-07-01	English
FORM 6-K Regulatory Filings	2026-07-01	English
FORM 6-K Major Shareholding Notification	2026-06-30	English
Change in substantial holding 6 pages 349.5KB Major Shareholding Notification	2026-06-30	English
FORM 6-K Director's Dealing	2026-06-17	English
Change of Director's Interest Notice x 2 5 pages 15.3KB Director's Dealing	2026-06-17	English
FORM 6-K Regulatory Filings	2026-06-16	English
Corporate Presentation June 2026 50 pages 3.9MB Investor Presentation	2026-06-16	English
FORM 6-K Regulatory Filings	2026-06-15	English
FORM 6-K Regulatory Filings	2026-06-15	English
Notification regarding unquoted securities - ATH 8 pages 23.0KB Regulatory Filings	2026-06-15	English
Notification of cessation of securities - ATH 5 pages 16.3KB Regulatory Filings	2026-06-15	English
FORM 6-K Regulatory Filings	2026-06-12	English
Completion of Consolidation 2 pages 193.4KB Capital/Financing Update	2026-06-12	English
FORM 6-K Regulatory Filings	2026-06-09	English
Alterity and FDA Agree on Phase 3 Program for ATH434 in MSA 5 pages 240.1KB Regulatory Filings	2026-06-09	English
FORM 6-K Regulatory Filings	2026-06-04	English
Share Consolidation Effective, Trading Under ATHDA 2 pages 175.9KB Share Issue/Capital Change	2026-06-04	English
Change of Registered Office Address 1 page 154.5KB Regulatory Filings	2026-06-03	English
FORM 6-K Regulatory Filings	2026-06-03	English
FORM 6-K Regulatory Filings	2026-05-29	English
Results of Meeting 3 pages 264.5KB Declaration of Voting Results & Voting Rights Announcements	2026-05-28	English
FORM 6-K Regulatory Filings	2026-05-19	English
Alterity Data Supports ATH434 Phase 3 Advancement in MSA 6 pages 275.7KB Regulatory Filings	2026-05-18	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Regulatory Filings	2026-05-12	English
Corporate Presentation May 2026 46 pages 3.4MB Investor Presentation	2026-05-11	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Regulatory Filings	2026-05-11	English
Alterity Announces Publication on MRI as Biomarker for MSA 5 pages 251.3KB Regulatory Filings	2026-05-10	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Regulatory Filings	2026-05-07	English
Alterity to Deliver Presentations at May Medical Meetings 3 pages 215.6KB Investor Presentation	2026-05-06	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Interim / Quarterly Report Q3 2026	2026-04-30	English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 449.2KB Interim / Quarterly Report Q3 2026	2026-04-29	English
Consolidation/Split - ATH 10 pages 33.1KB Share Issue/Capital Change	2026-04-29	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Regulatory Filings	2026-04-29	English
Notice of General Meeting/Proxy Form 29 pages 713.4KB Proxy Solicitation & Information Statement	2026-04-28	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Regulatory Filings	2026-04-27	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Major Shareholding Notification	2026-04-27	English
Alterity Receives Positive FDA Feedback on CMC Meeting 3 pages 189.7KB Regulatory Filings	2026-04-26	English
Change in substantial holding 6 pages 351.8KB Major Shareholding Notification	2026-04-23	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Regulatory Filings	2026-04-22	English
Alterity Presents New Analysis of ATH434 Phase 2 Data at AAN 4 pages 228.0KB Regulatory Filings	2026-04-21	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Director's Dealing	2026-04-21	English
Initial Director's Interest Notice - Cunningham 2 pages 251.2KB Director's Dealing	2026-04-20	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Regulatory Filings	2026-04-20	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Regulatory Filings	2026-04-20	English
Notification regarding unquoted securities - ATH 8 pages 21.9KB Share Issue/Capital Change	2026-04-19	English
Notification regarding unquoted securities - ATH 8 pages 21.9KB Share Issue/Capital Change	2026-04-19	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Board/Management Information	2026-04-17	English
Alterity Appoints Biotech Executive Ann Cunningham to Board 3 pages 190.4KB Board/Management Information	2026-04-16	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Regulatory Filings	2026-04-16	English
Alterity Announces Late-Breaker Oral Presentation at AAN 3 pages 184.6KB Regulatory Filings	2026-04-15	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Regulatory Filings	2026-04-15	English
Alterity to Host KOL Event to Share New Insights on ATH434 4 pages 223.0KB Regulatory Filings	2026-04-14	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Investor Presentation	2026-04-01	English
Corporate Presentation April 2026 39 pages 1.9MB Investor Presentation	2026-03-31	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Regulatory Filings	2026-03-30	English
Alterity Receives Positive FDA Feedback From Type C Meeting 3 pages 187.0KB Regulatory Filings	2026-03-29	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Regulatory Filings	2026-03-26	English
Notification regarding unquoted securities - ATH 8 pages 21.8KB Share Issue/Capital Change	2026-03-25	English
6-K - ALTERITY THERAPEUTICS LTD (0001131343) (Filer) Regulatory Filings	2026-03-19	English
Proposed issue of securities - ATH 5 pages 18.8KB Capital/Financing Update	2026-03-18	English
Unmarketable Parcel Sale Facility 8 pages 527.9KB Capital/Financing Update	2026-03-11	English
Alterity to Participate in the Bell Potter Healthcare Summit 2 pages 182.2KB Regulatory Filings	2026-03-08	English
Dr Daniel Claassen as Chief Medical Advisor 3 pages 190.2KB Board/Management Information	2026-03-03	English
Half Yearly Report and Accounts 27 pages 1.6MB Regulatory Filings	2026-02-25	English
6-K Filing Interim / Quarterly Report Q2 2026	2026-01-30	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 496.4KB Interim / Quarterly Report Q2 2026	2026-01-29	English
ATH Shareholder Letter January 2026 5 pages 247.7KB Management Reports	2026-01-20	English
6-K Filing Regulatory Filings	2026-01-15	English
6-K Filing Regulatory Filings	2026-01-15	English
Notification regarding unquoted securities - ATH 6 pages 19.6KB Share Issue/Capital Change	2026-01-14	English
Notification regarding unquoted securities - ATH 6 pages 19.6KB Share Issue/Capital Change	2026-01-14	English
6-K Filing Regulatory Filings	2026-01-13	English
Corporate Presentation 37 pages 2.3MB Investor Presentation	2026-01-12	English
6-K Filing Director's Dealing	2026-01-07	English
6-K Filing Regulatory Filings	2026-01-07	English
Notification of cessation of securities - ATH 5 pages 16.1KB Share Issue/Capital Change	2026-01-06	English
Change of Director's Interest Notice - D Stamler 3 pages 938.4KB Regulatory Filings	2026-01-06	English

Filings by year

2026 84 filings
2025 190 filings
2024 161 filings
2023 143 filings
2022 113 filings
2021 107 filings
2020 149 filings
2019 89 filings
2018 61 filings
2017 67 filings
2016 59 filings
2015 51 filings
2014 98 filings
2013 111 filings
2012 112 filings
2011 112 filings
2010 75 filings
2009 81 filings
2008 131 filings
2007 105 filings
2006 85 filings
2005 50 filings
2004 75 filings
2003 52 filings
2002 9 filings